Sanofi/€SAN
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Sanofi
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
- Ticker
- €SAN
- Sector
- Health
- Primary listing
- PAR
- Employees
- 74,846
- Headquarters
- Paris, France
- Website
- www.sanofi.com
Sanofi Metrics
BasicAdvanced
€90bn
23.23
€3.26
0.28
€4.12
5.43%
Price and volume
Market cap
€90bn
Beta
0.28
52-week high
€90.90
52-week low
€71.25
Average daily volume
2.2m
Dividend rate
€4.12
Financial strength
Current ratio
0.987
Quick ratio
0.487
Long term debt to equity
23.464
Total debt to equity
33.89
Dividend payout ratio (TTM)
244.95%
Interest coverage (TTM)
22.49%
Profitability
EBITDA (TTM)
13,543
Gross margin (TTM)
73.45%
Net profit margin (TTM)
8.09%
Operating margin (TTM)
21.20%
Effective tax rate (TTM)
23.16%
Revenue per employee (TTM)
€650,000
Management effectiveness
Return on assets (TTM)
5.09%
Return on equity (TTM)
5.71%
Valuation
Price to earnings (TTM)
23.232
Price to revenue (TTM)
1.872
Price to book
1.31
Price to tangible book (TTM)
10.13
Price to free cash flow (TTM)
10.872
Free cash flow yield (TTM)
9.20%
Free cash flow per share (TTM)
6.974
Dividend yield (TTM)
5.43%
Forward dividend yield
5.43%
Growth
Revenue change (TTM)
6.95%
Earnings per share change (TTM)
-55.56%
3-year revenue growth (CAGR)
2.04%
10-year revenue growth (CAGR)
3.67%
3-year earnings per share growth (CAGR)
-21.97%
10-year earnings per share growth (CAGR)
0.16%
3-year dividend per share growth (CAGR)
4.99%
10-year dividend per share growth (CAGR)
3.47%
What the Analysts think about Sanofi
Analyst ratings (Buy, Hold, Sell) for Sanofi stock.
Sanofi Financial Performance
Revenues and expenses
Sanofi Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.